AirSculpt Technologies, Inc. announced its third-quarter results, with a 15.2% decline in case volume and a 17.8% drop in revenue compared to the same period in 2024. Net loss was $9.5 million, and Adjusted EBITDA was $3.0 million. The company expects full-year revenue of approximately $153 million and adjusted EBITDA of $16 million.

Yogi Jashnani, CEO, highlighted the company’s progress in key initiatives despite lower third-quarter revenue. The company is positioned to benefit from the aesthetics market shift due to GLP-1 use. AirSculpt’s new CFO, Michael Arthur, will join on January 5, 2026. The company remains confident in delivering long-term growth and shareholder value.

As of September 30, 2025, AirSculpt had $5.4 million in cash and cash equivalents, generating $5.6 million in operating cash flow for the first nine months of the year. The company was compliant with its bank covenants. A conference call to discuss the results will be held on November 7, 2025, at 8:30 am.

AirSculpt’s next-generation body contouring treatment, AirSculpt, is designed for comfort and precision, offering minimally invasive fat removal and skin tightening. The company’s financial results are reported using non-GAAP measures like Adjusted EBITDA and Adjusted Net Income, which help assess the company’s operating performance effectively. For more information, visit AirSculpt’s website.

Read more at GlobeNewswire: AirSculpt Technologies Reports Third Quarter Fiscal 2025